secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001193125-25-111633
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics sets 2025 Annual Meeting for July 9; shareholder proposal deadline May 12
--------------------------------------------------------------------------------

- Annual Meeting scheduled for July 9, 2025; record date for voting is May 19, 2025.
- Shareholder proposals under Rule 14a-8 must be received by May 12, 2025.
- Director nominations and other proposals under bylaws also due by May 12, 2025.
- Meeting delayed more than 30 days from 2024 anniversary, triggering this 8-K notice.
- Stockholders intending to use universal proxy rules must provide Rule 14a-19 notice by May 12, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000119312525111633/0001193125-25-111633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000119312525111633/d830663d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-111633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer